Hrt Financial LP Nektar Therapeutics Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.42 - $0.57 $15,259 - $20,709	36,333 Added 106.34%	70,500 $39,000
Q3 2023 Nov 13, 2023	SELL	$0.51 - $1.05 $102,045 - $210,094	-200,090 Reduced 85.41%	34,167 $20,000
Q2 2023 Aug 11, 2023	SELL	$0.53 - $1.03 $76,775 - $149,205	-144,860 Reduced 38.21%	234,257 $134,000
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $26,456 - $130,214	-41,338 Reduced 9.83%	379,117 $266,000
Q4 2022 Feb 10, 2023	BUY	$2.03 - $4.28 $380,929 - $803,142	187,650 Added 80.6%	420,455 $950,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $362,808 - $613,433	119,345 Added 105.19%	232,805 $744,000
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $717,859 - $1.4 Million	-226,454 Reduced 66.62%	113,460 $431,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $1.41 Million - $4.66 Million	339,914 New	339,914 $1.83 Million
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $340,841 - $579,399	-31,472 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $10,194 - $14,695	780 Added 2.54%	31,472 $565,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $114,830 - $141,800	6,951 Added 29.28%	30,692 $526,000
Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $393,150 - $604,445	23,741 New	23,741 $474,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $258,959 - $312,491	-16,421 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $22,379 - $33,441	-1,349 Reduced 7.59%	16,421 $272,000
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $299,602 - $416,528	17,770 New	17,770 $411,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $165,015 - $318,855	-11,404 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $43,166 - $62,886	-2,720 Reduced 19.26%	11,404 $246,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $92,988 - $199,448	5,499 Added 63.76%	14,124 $257,000
Q2 2018 Aug 15, 2018	BUY	$46.25 - $104.45 $398,906 - $900,881	8,625 New	8,625 $421,000

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$15.1 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$14.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$12.5 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.93 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.74 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $178M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account